Data from EMA (European Medicines Agency) - Curated by EPG Health - Last updated 13 June 2018

Indication(s)

- NovoMix 30 Penfill 100 units/ml suspension for injection in cartridge
- NovoMix 30 FlexPen 100 units/ml suspension for injection in pre-filled pen

NovoMix 30 is indicated for treatment of diabetes mellitus in adults, adolescents and children aged 10 years and above.



- NovoMix 50 Penfill 100 units/ml suspension for injection in cartridge
- NovoMix 50 FlexPen 100 units/ml suspension for injection in pre-filled pen

NovoMix 50 is indicated for treatment of diabetes mellitus in adults.



- NovoMix 70 Penfill 100 units/ml suspension for injection in cartridge
- NovoMix 70 FlexPen 100 units/ml suspension for injection in pre-filled pen

NovoMix 70 is indicated for treatment of diabetes mellitus in adults.

Full Prescribing information

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Atopic Dermatitis

Atopic Dermatitis

The Atopic Dermatitis Knowledge Centre is an educational resource, intended for healthcare professionals, that provides credible medical information on the epidemiology, pathophysiology and burden of atopic dermatitis, as well as diagnostic techniques, treatment regimens and guideline recommendations.

Cushing's Syndrome

Cushing's Syndrome

Cushing’s syndrome shares symptoms such as hypertension, glucose intolerance and obesity with other common conditions – how can you confidently diagnose this rare disorder?

+ 2 more

Chronic Spontaneous Urticaria (CSU)

Chronic Spontaneous Urticaria (CSU)

Use our patient case studies to discover how experts diagnose and treat chronic spontaneous urticaria.

+ 7 more

Load more

Related Content

Journal articles

Chromosome 6q24-related diabetes mellitus.

Chromosome 6q24-related diabetes mellitus is the most common cause of transient neonatal diabetes (TNDM), accounting for approximately two-thirds of all TNDM cases.

Added 8 months ago

The potential effect of ultra-long insulin degludec on glycemic variability.

Despite the therapeutic advances in the treatment of diabetes, metabolic control instability due to glycemic variability (GV) is frequently observed in patients with diabetes on intensive insulin therapy and is associated with...

Added 1 year ago

Outcomes of bariatric surgery in the young: a single-institution experience caring for patients under 21 years old.

Background: Medical weight loss options are rarely successful long term in young patients. Bariatric surgery has been shown to be...

Added 2 years ago

Influence of initial insulin dosage on blood glucose dynamics of children and adolescents with newly diagnosed type 1 diabetes mellitus.

Objective: To investigate the effect of initial insulin dosage on blood glucose (BG) dynamics, β-cell protection, and oxidative stress in...

Added 2 years ago

Load more

View all 12845 Journal articles items
Guidelines

Diabetes (type 1 and type 2) in children and young people: diagnosis and management

This guideline covers the diagnosis and management of type 1 and type 2 diabetes in children and young people aged under 18.

Added 3 years ago

Type 1 diabetes in adults: diagnosis and management

This guideline covers the care and treatment of adults (aged 18 and over) with type 1 diabetes.

Added 3 years ago

ISPAD Clinical Practice Consensus Guidelines 2014

This supplement of Pediatric Diabetes is an update of the guideline chapters that were originally individually published in the journal between 2006 and 2008, and as a single compendium edition in 2009.

Added 4 years ago

Load more

View all 1443 Guidelines items

More information

Category Value
Agency product number EMEA/H/C/000308
Orphan designation No
Date First Approved 01-08-2000
Type Medicinal product subject to medical prescription
Marketing authorisation holder Novo Nordisk A/S